In Vitro System for Orally Inhaled Drug Release
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Discover the development of an in vitro dissolution and release system from Nanopharm for OINDPs (orally inhaled drug products).
Regional Deposition in Generic Dry Powder Inhalers
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm investigate regional deposition and simulated inhaled pharmacokinetic profiles of generic dry powder inhalers.
Faster, Cost-Effective Alternative to Generic Bioequivalence
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Discover SmartTrack to advance the development of OINDPs. Streamline inhalation and nasal therapies with optimized particle size distribution.
Mixed Kinetic Model of Inhaled Corticosteroid Dissolution
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore the dissolution kinetics of inhaled pharmaceuticals in dry powder inhalers (DPI) and pressurized metered dose inhalers (pMDI).
Automated Classification of DPI Agglomerate Particles
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore automated classification of dry powder inhaler particles using Cluster Analysis and Morphologically Directed Raman Spectroscopy.
Challenges in OINDPs Achieving Q3 Equivalence
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm review the bioequivalence challenges for OINDPs by achieving Q3 structural equivalence.
Trade Marks Registration Certificate for Nanopharm Ltd
![](https://nanopharm.co.uk/wp-content/uploads/2023/07/Nanopharmlogo.png)
Discover Nanopharm’s leading role in pharmaceutical research, specializing in OINDP, nasal, and inhaled pharmaceutical solutions.
Structural Dynamics of Fluticasone Propionate Processing
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm explores the effect of secondary processing on the structural relaxation dynamics of Fluticasone Propionate.
Secondary Processing’s Effect on Fluticasone Dynamics
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore the effect of secondary processing on the structural relaxation dynamics of Fluticasone Propionate in DPIs.
Cohesive-Adhesive Balances in DPIs
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore Dry Powder Inhaler development through Atomic Force Microscopy. Uncover Cohesive-Adhesive balances in OINDP for effective inhaler formulations.